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A novel opioid peptide, Tyr-Pro-Be-Ser-Leu, was isolated from the pepsin-trypsin-chymotrypsin digest of wheat gluten. Its IC,, values were 40 
PM and 13.5 PM in the GPI and MVD assays, respectively. This peptide was named gluten exorphin C. Gluten exorphin C had a structure quite 
different from any of the endogenous and exogenous opioid peptides ever reported in that the N-terminal Tyr was the only aromatic amino acid. 
The analogs containing Tyr-Pro-X-Ser-Leu were synthesized to study its StructLlre~activity relationship. Peptides in which X was an aromatic 
amino acid or an aiiphatic hydrophobic amino acid had opioid activity. 
Opioid peptide; Wheat; Gluten; Exorphin 
1. INTRODUCTION one was from U.S.P.C., Inc. 13HJDAG0 and [“HIDADLE were from 
Amersham. Other reagents used were of reagent grade or better. 
The presence of the opioid peptides has been recog- 
nized in the pepsin digest of wheat gluten [1,2]. How- 
ever, there was no report about their structure and char- 
acter. Recently, we observed that the opioid activity in 
the digest obtained by further hydrolyses of the pepsin 
digest with microbial protease thermolysin was more 
potent than that in the pepsin digest and four novel 
opioid peptides, Gly-Tyr-Tyr-Pro-Thr, Gly-Tyr-Tyr- 
Pro, Tyr-Gly-Gly-Trp-Leu and Tyr-Gly-Gly-Trp, were 
isolated from the pepsin-thermolysin digest [3]. They 
were named gluten exorphins A5, A4, B.5 and B4, re- 
spectively. On the other hand, we also found high- 
opioid activity in the digest treated with only gastro- 
intestinal proteases, pepsin, trypsin and chymotrypsin 
131. In this study, we isolated a new opioid peptide, 
which had a peculiar structure-activity relationship, 
from the pepsin-t~psin~hymotrypsill digest of wheat 
gluten. 
2.2. Enqnzatic digestion of wheat gluten 
Wheat gluten (50 mg/ml solution) was digested with pepsin (0.5 
mg/ml) in 0.02 N HCl (pH 2.0) for 17 h at 36°C. After the digestion. 
the pH of the solution was adjusted with 1 N NaOH to 7.0. The 
solution was then boiled and centrifuged. The supernatant was lyo- 
philized. The peptic digest (50 mg/ml solution) was further digested 
with trypsin and chymotrypsin (0.5 mg/ml, respectively) in distilled 
water for 5 h at 36”C, boiled and centrifuged. 
2.3. Pur$cation ofpeptides 
2. MATERIALS AND METHODS 
2.1. Chemicals and reagents 
Separation of peptides in the digest was accomplished by reversed- 
phase HPLC on an ODS column (Cosmosil S&-AR, 20 x 250 mm. 
Nacalai Tesque Inc.). A 100 mg digest was applied to the column and 
eluted with a linear gradient between 0 to 40% acetonitrile containing 
0.05% TFA at 10 ml/min. The eluate was monitored at 230 nm. 
Individual fractions were dried with a centrifugal concentrator and 
their opioid activities were measured with the MVD assay. The opioid 
active fractions were purified on an ODS column (Cosmosil5 C,,-AR, 
4.6 x 150 mm), a phenyl silica column (Cosmosil 5Ph, 4.6 x 250 mm) 
and ~yanopropyl silica column (Cosmosii SCN-R, 4.6 x 250 mm) from 
Nacalai Tesque Inc. The columns were developed by a linear gradient 
between 0 to 50% acetonitrile co~l~iningO.O5% TFA or 10 mM potas- 
sium-sodium phosphate buffer (pH 7) at 1 mllmin. The eluate was 
monitored at 215 nm to 235 nm. As a first step, the active fractions 
were purified on the same ODS column. 
Wheat gluten was obtained from Goodman Fielder Mills Ltd. Pep- 
sin, trypsin and chymotrypsill were from Sigma Chemical Co. Nalox- 
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2.4. Amino ucid sequence anulysrs and peptide synthesis 
The amino acid sequence of the purified peptide was analyzed by 
a 477A protein sequencer (Applied Biosystems Inc.). Peptides were 
synthesized by Sam 2 peptide synthesizer (Biosearch Inc.) according 
to the t-butyloxycarbonyl strategy. Peptides were deprotected by the 
anisol/hydrogen fluoride method and purified by reversed-phase 
HPLC on an ODS column. The structures of synthesized peptides 
were confirmed by a protein sequencer. 
Abb~e~li~t~o~.~~ GPI, guinea pig ileum; MVD, mouse vas deferens; 
DAGO, [DAla~,MePhe4,Glyo15]enkep~lin; DADLE, [oAla2,nLeuS] 
enkephalin; ODS, octadecyl silica; HPLC, high-perfomrance liquid 
chromatography; TFA, trifluoroacetic acid. 
2.5. Opioid activity m.m~:~ und radioreceptor ussays 
Opioid activity assays and radioreceptor assays were performed as 
previously described 131. 
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Fig. 1. Reversed-phase HPLC of the pepsintrypsin-chymotrypsin digest on an ODS column. 
3. RESULTS AND DISCUSSION 
In the previous paper, we reported the presence of 
opioid activity in the pepsin-trypsin-chymotrypsin di- 
gest of wheat gluten using the MVD assay [3]. This 
digest was fractionated by reversed-phase HPLC on an 
ODS column and opioid activities of the individual frac- 
tions were measured using the MVD assay. The opioid 
activity was eluted at about 31 to 32% acetonitrile (Fig. 
1, Table I). This opioid active fraction from the ODS 
column was purified by reversed-phase HPLC on the 
other columns (Table I). The purified peptide was 
analysed with a protein sequencer and the sequence 
obtained was Tyr-Pro-Ile-Ser-Leu. This peptide was 
named gluten exorphin C. The yield of this peptide 
against wheat gluten was 4 x IO-j%. However, the se- 
quence which corresponded to gluten exorphin C was 
not found in the primary structure of gliadin or glutenin 
reported until now. This peptide might be derived from 
Table I 
Purification of the opioid peptide derived from the pepsintrypsin- 
chymatrypsin digest of wheat gluten. This table shows the acetonitrile 
concentrations in which opioid active fractions were eluted in various 
reversed-phase HPLC. 
Column ODS” Phenyl” Cyano- ODS” 
propyl” 
____________________________________________~~~~~~_________-~~~~~~~~~__________________ 
Column size (mm) 20 x 250 4.6 x 250 4.6 x 250 4.6 x 150 
- 
Elution condition 31.5 33.0 27.5 24.0 
(% acetonitrile) 
* In the presence of 0.05% TFA 
‘In the presence of 10 mM potassium-sodium phosphate buffer 
(PH 7). 
18 
a wheat protein of which the primary structure has not 
yet been determined. 
Gluten exorphin C was isolated from the digest which 
is hydrolyzed with only gastro-intestinal proteases, pep- 
sin, trypsin and chymotrypsin. This means that this 
peptide is certainly released in digestive organs after the 
ingestion of wheat gluten. It has been reported that the 
oral administration of the peptic digest of wheat gluten 
influenced the regulation of gastro-intestinal motility 
and hormone release, and these effects were reversed by 
naloxone [4-61. In this respect, it might be possible that 
gluten exorphin C is responsible for such a regulation 
of physiological functions. 
We synthesized gluten exorphin C and evaluated its 
opioid activities by the GPI and MVD assays and its 
receptor affinities by radioreceptor assays. Its IC,, val- 
ues were 40 ,uM and 13.5 ,uM in the GPI and the MVD 
assays, respectively (Table II). Together with the radi- 
oreceptor assay results, this peptide was a rather &- 
selective ligand. All of the endogenous and exogenous 
opioid peptides ever reported have an N-terminal Tyr 
and a second aromatic amino acid residue at positions 
2 or 3. Especially, in enkephalins (Tyr-Gly-Gly-Phe- 
Met/ Leu), it is reported that Phe at position 4 was 
important for S-receptor affinity [7]. In addition, ex- 
ogenous opioid peptides containing the Tyr-Pro se- 
quence, &casomorphin 7 (Tyr-Pro-Phe-Pro-Gly-Pro- 
Ile), hemorphin 4 (Tyr-Pro-Trp-Thr) and cytochrophin 
4 (Tyr-Pro-Phe- Thr) have a second aromatic amino 
acid residue such as Phe or Trp at position 3 [&lo]. In 
this respect, gluten exorphin C is a characteristic opioid 
peptide in that the N-terminal Tyr is the only aromatic 
amino acid residue in the structure. 
Therefore, we synthesized the analogs of gluten exor- 
phin C of which the structure was displayed as Tyr-Pro- 
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Table II 
Opioid activities and receptor affinities of gluten exotphin C and its analogs 
Peptides 
Opioid acttvttres (IC,,) 
GPI 
~_ 
MVD 
Tyr-Pro-Ile-Ser-Leu 
(gluten exorphin C) 
Tyr-Pro-Val--Ser-Leu 
Tyr-Pro-LewSer-Leu 
Tyr-Pro-Lys-Ser-Leu 
Tyr--Pro-Ala-Ser-Leu 
Tyr--Pro-Thr-Ser-Leu 
Tyr-Pro-Nva-Ser-Leu 
Tyr--Pro-Nle-Ser-Leu 
Tyr--Pro-Phe-Ser-Leu 
Tyr--Pro-Trp-Ser-Leu 
40 13.5 
200 200 
200 200 
>lOOO >I000 
>I000 >lOOO 
~1000 >lOOO 
33 14.0 
30 15.0 
30 70 
20 70 
3.0 
Receptor affinities (IC,,) 
vH]DAGO 13H]DADLE 
--~ 
fi luM) 6 01M) 
110 30 
350 150 
540 110 
>lOOO >lOOO 
940 500 
>lOOO 400 
200 74 
96 70 
64 38 
13 8 
3.7 
2.3 
4.9 
- 
1.9 
2.7 
1.4 
1.7 
1.6 
X-Ser-Leu to study its structureeactivity relationship 
and evaluate their opioid activities and receptor affini- 
ties (Table II). The analogs in which X were aliphatic 
hydrophobic amino acids (Val, Leu) were less potent 
than gluten exorphin C. In the case when X was a 
straight chain aliphatic hydrophobic amino acid (Nva 
or Nle), their potencies were almost the same as gluten 
exorphin C. On the other hand, the analogs in which X 
was a basic or hydrophilic amino acid (Lys, Ala, Thr) 
had almost no activity. /I-Casomorphin 7- and hemor- 
phin 4-like analogs in which X was replaced by an aro- 
matic amino acid (Phe or Trp) showed almost the same 
activity to gluten exorphin C in the GPI assay. 
These results can be summarized by stating that the 
Tyr-Pro-X-Ser-Leu analogs in which X was represented 
by an aliphatic hydrophobic amino acid or an aromatic 
amino acid had opioid activity and that the variation of 
the hydrophobic amino acid at position 3 greatly af- 
fected their opioid activity. In this respect, it was sug- 
gested that the hydrophobicity of Ile3 was important for 
the expression of the opioid activity of gluten exorphin 
C. From the present study of the isolation and of the 
structure-activity relationship of gluten exorphin C, it 
is concluded that the second aromatic amino acid at 
position 3 is not essential for the opioid activity of pep- 
tides having the Tyr-Pro sequence. 
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